Delivery Order SPE2DB22D2206-SPE2DB24FHX93
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,911.09 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a medication, with an ultimate completion date of March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,664.24 firm fixed-price delivery order is for the supply of 4559656211 GLATIRAMER 40 MG/ML syringes, with a completion date of January 20, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,511.18, is for the delivery of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,088.20 firm fixed-price delivery order contract is for the supply of GLATIRAMER 40 MG/ML SYRINGE medication, with a period of performance through July 11, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,832.12 Firm Fixed Price delivery order is for the supply of 4560559530 units of glatiramer 40 mg/ml syringes, with a performance period ending on April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,888.08, is for the delivery of Glatiramer 40 mg/mL syringes. The contract has a firm fixed price pricing type and an ultimate completion date of March 29, 2024. The award was made on March 28, 2024 and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564082002 - GLATIRAMER 40 MG/ML SYRINGEML. The award, valued at $2,937.92, has a period of performance through March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award is a delivery order valued at $13,340.83 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award was issued by the Defense Logistics Agency (DLA), a defense agency, for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price pricing type and runs through February 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,189.76 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 27, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,328.78, is for the delivery of COPAXONE 40 MG/ML syringes, a specialty medication. The contract has an ultimate completion date of June 17, 2024 and is a Firm Fixed Price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...